Search

Author/Creator Silverberg, Jonathan I

2. 321 Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: systematic review and Bayesian meta-analysis. (25th January 2023)

Authors:
Chu, Alexandro W L; Devasenapathy, Niveditha; Wong, Melanie; Srivastava, Archita; Ceccacci, Renata; Lin, Clement; MacDonald, Margaret; Wen, Aaron; Steen, Jeremy; Levine, Mitchell; Pyne, Lonnie; Wang, Julie; Spergel, Jonathan M; Silverberg, Jonathan I; Ong, Peck Y; O'Brien, Monica; Martin, Stephan...
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 322 Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized, double-blinded, placebo-controlled phase 3 trials (ADvocate1 and ADvocate2). (25th January 2023)

Authors:
Blauvelt, Andrew; Thyssen, Jacob P; Guttman-Yassky, Emma ; Bieber, Thomas; Carrascosa, Jose Manuel; Simpson, Eric; Rosmarin, David ; Elmaraghy, Hany; Meskimen, Eric; Natalie, Chitra R; Liu, Zhuqing; Xu, Chenjia; Pierce, Evangeline; Morgan-Cox, MaryAnn; Silverberg, Jonathan I
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 327 Optimizing the management of atopic dermatitis with a new minimal disease activity concept and criteria and consensus-based recommendations for systemic therapy. (25th January 2023)

Authors:
Silverberg, Jonathan I; Gooderham, Melinda; Katoh, Norito; Aoki, Valeria; Pink, Andrew E; Binamer, Yousef; Wollenberg, Andreas
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 328 Understanding the impact of atopic dermatitis on patients: a large international, ethnically diverse survey-based qualitative study. (25th January 2023)

Authors:
Wollenberg, Andreas; Gooderham, Melinda; Katoh, Norito; Aoki, Valeria; Pink, Andrew E; Binamer, Yousef; Silverberg, Jonathan I
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 330 Safety of abrocitinib in 3582 patients with moderate-to-severe atopic dermatitis with over 900 patients exposed for almost 2 years. (25th January 2023)

Authors:
Simpson, Eric L; Silverberg, Jonathan I; Nosbaum, Audrey; Winthrop, Kevin; Guttman-Yassky, Emma; Hoffmeister, Karin M; Egeberg, Alexander; Valdez, Hernan; Fan, Haiyun; Farooqui, Saleem A; Chan, Gary; Alderfer, Justine; Romero, William; Johnson, Susan
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 339 Dupilumab 16-week efficacy and safety are robust and consistent in adults over 60 years of age with moderate-to-severe atopic dermatitis. (25th January 2023)

Authors:
Silverberg, Jonathan I; Lynde, Charles W; Abuabara, Katrina; Patruno, Cataldo; De Benedetto, Anna; Khokhar, Faisal A; Marco, Ainara Rodriguez; Levit, Noah A
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 348 Development and validation of a claims-based algorithm for moderate-to-severe atopic dermatitis using U.S. real-world data. (25th January 2023)

Authors:
Chomistek, Andrea K; Franklin, Jessica M; Sobel, Rachel; Marcus, Andrea; Sinnott, Sarah-Jo; Howell, Ashley; Sultan, Ihtisham; Silverberg, Jonathan I; Wang, Florence T
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. 350 Examining the relationships among abrocitinib treatment, itch, skin pain and work and activity impairments in patients with atopic dermatitis: a mediation modelling analysis. (25th January 2023)

Authors:
Silverberg, Jonathan I; Ständer, Sonja; Thyssen, Jacob P; Kim, Brian S; Castro, Carla; Bewley, Anthony; Misery, Laurent; Bushmakin, Andrew G; Cappelleri, Joseph C; Guler, Erman; Alderfer, Justine; Watkins, Melisa; Chan, Gary; Myers, Daniela E
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. 351 Examining the relationships among abrocitinib treatment, itch, skin pain and dermatology-specific quality of life in patients with atopic dermatitis: a mediation modelling analysis. (25th January 2023)

Authors:
Silverberg, Jonathan I; Ständer, Sonja; Thyssen, Jacob P; Kim, Brian S; Castro, Carla; Bewley, Anthony; Misery, Laurent; Bushmakin, Andrew G; Cappelleri, Joseph C; Guler, Erman; Alderfer, Justine; Watkins, Melissa; Chan, Gary; Myers, Daniela E
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗